http://www.oxford-instruments.com/Pages/home.aspx


Oxford Instruments is a leading provider of high technology tools and systems for research and industry. We design and manufacture equipment that can fabricate, analyse and manipulate matter at the atomic and molecular level.

Oxford Instruments has discrete business groups operating in three sectors. This means we can focus our expertise, our technologies and our innovation on offering our customers high quality products and service that meet their stringent requirements.







Financial Calendar


Half Year/Interim Results Announcement

Tuesday November 13th 2012 : 9.30am The London Stock Exchange

Annual General Meeting:

Tuesday 11th September 2012 : 2.30pm

Oxford Instruments plc, Tubney Woods, Abingdon, Oxon OX13 4QX

26 September 2012 Ordinary shares quoted ex-dividend
28 September 2012 Record date for final dividend
30 September 2012 DRIP date
25 October 2012 Payment of final dividend
March 2013 Ordinary shares quoted ex-dividend
Dividend reinvestment (DRIP) last date for election
Record date for interim dividend
31 March 2013 Financial Year End

Oxford Instruments on track to meet expectations
10:08 am by Sergei Balashov Shares in Oxford Instruments fell this morning after the group revealed that there has been "some softness" in its industrial markets
Oxford Instruments (LON:OXIG) said trading remains in line with expectations, but reported that there has been "some softness" in its industrial markets.

The group, which provides high technology tools and systems for industry and research, told investors that it is set to achieve its targets of a 14 percent increase in revenues and a 14 percent return on sales by the end of the financial year 2013/14.

In the year to March 2012, the company’s sales climbed 29 percent split equally between organic growth and three bolt on acquisitions.

Return on sales also improved within its targets, climbing to 12.5 percent from 10.7 percent.

In the current year, the group’s nanotechnology tools business has made good progress, while the industrial division has continued to trade in line with expectations.

The service unit has performed well providing aftermarket service to the installed base of Oxford Instruments equipment.

However, the group reported that while order intake from its research markets remains good, there has been “some softness” in its industrial markets.

“Despite the ongoing uncertainties in global economies, we believe the diversity of our activities combined with our strong pipe-line of new products will continue to provide good growth opportunities for the group,” said chairman of Oxford Instruments Nigel Keen.

“The board anticipates that Oxford Instruments will continue to make progress in line with our expectations for the financial year.”

Shares in the group were changing hands at 1,296 pence at 10am, down five percent from Monday’s close.

A buy recommendation in this weeks IC - The mere mention of ''some softness'' in order intake from its industrial markets helped chop as much as 10 per cent off the company share price. In an otherwise innocuous update, Oxford confirmed good progress at its high-profit-margin nanotechnology tools and services division since the March year-end, and added that the industrial unit is trading in line with expectations,
keeping the company on track to hit full-year targets. At 1288 the shares are a buy.

http://www.thisismoney.co.uk/money/investing/article-2203796/MIDAS-UPDATE-Tool-maker-Oxford-Instruments-tipped-rises-588.html

Interesting movements today on these I notice. might have been something to do with witching hour though.

Nice 5% rise today, welcomed as they have slipped a bit recently.

25 October 2012
Payment of final dividend

13th November 2012 (9.30am)
Half Year/Interim Results Announcement, The London Stock Exchange

13 Nov gives us half year figures, the results themselves are likely to be largely as expected, guidance on future revenues and profits should be very encouraging. Back in Sept the £747 million cap reported stellar order intake from its nano research markets, alongside unsurprising softness across some of its industrial market customers. Industrial demand should improve as economies pick up. Analysts at broker Investec are championing the prospects for 'strong growth and successive earnings upgrades'. The broker expects 5% earnings per share (EPS) growth to 64.8p for the 12 months to March 2013, followed by a further 15% advance to74.3p
A buy in this weeks shares mag.

RNS Number : 9243Q

Oxford Instruments PLC

13 November 2012






Release Date: 7am Tuesday 13th November 2012



Oxford Instruments plc

Announcement of Half Year Results for 2012/13



Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces its Half Year Results for the six months to 30 September 2012.



Highlights:

· Good progress in the first half, in line with meeting our 14 Cubed growth plan objectives

· Revenue up 7.4% to £170.8 million (2011: £159.1 million)

· Adjusted profit before tax* up 23.5% to £23.1 million (2011: £18.7 million)

· Adjusted EPS* up 20.2% to 33.9 pence (2011: 28.2 pence)

· Reported EPS up 25.1% to 20.9 pence (2011: 16.7 pence)

· Continued increase in global demand for nanotechnology tools

· Focused R&D programme continued to underpin organic growth

· New product pipeline remains strong

· Net cash of £37.1 million at period end (2011: £11.9 million)

· Interim dividend increased by 10.1% to 3.05 pence (2011: 2.77 pence)



*Adjusted numbers are stated to give a better understanding of the underlying business. Details of adjusting items can be found in Note 2.



Jonathan Flint, Chief Executive of Oxford Instruments plc, said:



"We have delivered a strong result in the first half in line with our 14 Cubed objectives. We have a broad spread of geographies and technologies, exposure to markets with long term structural growth, a strong pipeline of new products and a focus on improving efficiency. These factors should help us to remain resilient against a backdrop of sustained global economic uncertainty. We are continuing our pursuit of acquisitions that have the potential to enhance shareholder value and add to our range of technical capabilities.



The Board remains confident in the continued growth prospects of Oxford Instruments and the Group's ability to deliver shareholder value."

Good results

They do look good DC don't they, But lets see what the market thinks as these has been on the slide leading up to these results.

Stan perhaps they will rebuild over the next few weeks. Again good set of results.

presentation -

Interim Results Announcement 2012/13

http://www.oxford-instruments.com/OxfordInstruments/media/global/investors/half-year-results-documents/2012/Oxford-Instruments-plc-Half-Year-Results-Presentation-November-13-2012.pdf

Oxford Instruments: Liberum Capital raises target price from 1445p to 1515p, buy rating kept

A buy in this weeks IC. Demand for Oxford instruments constantly evolving range of nanotechnology tools is growing fast. In the first half, adjusted pre-tax profit jumped 24% to £23.1m, which was better than expected, and the high-tech instrument ation specialist is close to hitting internal targets two years early. Once again most of the growth came from China. Sales in Asia grew 23%, easily out-strippingNorth America and Europe. A 200-basis point increase in adjusted operating margin puts Oxford within easy reach of its target of 14% by 2014, and analysts think it could rise to 20% in time. The strongest performance came from nano tools , which posted a 42% rise in profits to £10.4m. Oxfords material characterisation system-used by law enforcement agencies to detect gunshot residue -sold more than expected, and it has not seen any cuts in research funding from governments, either. And the more cyclical industrial unit stillraised profits by 15%, driven by demand for its hand held analysers such as those used to detect heavy metal contamination at the London Olmpic village. Sales of rock core analysers that detect shale oil and gas gushed 80%during the first half, too.
India could be the next big thing , Its pumping cash into the university system and, although its about 8-10 years behind China, offers plenty of opportunity.
Funding for nanotechnology research is growing by 10-20% a year and Oxford Instruments potential to beat both estimates and its own targets justifies a forward PE ratio of 19.

A buy in this weeks IC. Demand for Oxford instruments constantly evolving range of nanotechnology tools is growing fast. In the first half, adjusted pre-tax profit jumped 24% to £23.1m, which was better than expected, and the high-tech instrument ation specialist is close to hitting internal targets two years early. Once again most of the growth came from China. Sales in Asia grew 23%, easily out-strippingNorth America and Europe. A 200-basis point increase in adjusted operating margin puts Oxford within easy reach of its target of 14% by 2014, and analysts think it could rise to 20% in time. The strongest performance came from nano tools , which posted a 42% rise in profits to £10.4m. Oxfords material characterisation system-used by law enforcement agencies to detect gunshot residue -sold more than expected, and it has not seen any cuts in research funding from governments, either. And the more cyclical industrial unit stillraised profits by 15%, driven by demand for its hand held analysers such as those used to detect heavy metal contamination at the London Olmpic village. Sales of rock core analysers that detect shale oil and gas gushed 80%during the first half, too.
India could be the next big thing , Its pumping cash into the university system and, although its about 8-10 years behind China, offers plenty of opportunity.
Funding for nanotechnology research is growing by 10-20% a year and Oxford Instruments potential to beat both estimates and its own targets justifies a forward PE ratio of 19.

:-))

Taken my eye off of this one, But still going up!

Oxford Instruments: Numis increases target price from 1380p to 1825p and maintains an add rating.

Oxford Instruments: JP Morgan takes target price from 1500p to 1750p and leaves its overweight rating unchanged.